nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CNR2—breast cancer	0.364	0.771	CbGaD
Rimonabant—CYP2D6—breast cancer	0.0582	0.123	CbGaD
Rimonabant—CYP3A4—breast cancer	0.0499	0.106	CbGaD
Rimonabant—CYP1A2—Anastrozole—breast cancer	0.0282	0.0839	CbGbCtD
Rimonabant—CYP1A2—Toremifene—breast cancer	0.0258	0.0767	CbGbCtD
Rimonabant—CYP2C9—Anastrozole—breast cancer	0.0254	0.0756	CbGbCtD
Rimonabant—CYP3A4—Exemestane—breast cancer	0.0195	0.058	CbGbCtD
Rimonabant—CYP2C9—Idarubicin—breast cancer	0.0193	0.0573	CbGbCtD
Rimonabant—CYP2D6—Idarubicin—breast cancer	0.0176	0.0524	CbGbCtD
Rimonabant—CYP3A4—Letrozole—breast cancer	0.0166	0.0493	CbGbCtD
Rimonabant—CYP3A4—Anastrozole—breast cancer	0.0148	0.0439	CbGbCtD
Rimonabant—CYP3A4—Toremifene—breast cancer	0.0135	0.0402	CbGbCtD
Rimonabant—CYP3A4—Fulvestrant—breast cancer	0.0126	0.0374	CbGbCtD
Rimonabant—CYP3A4—Thiotepa—breast cancer	0.0112	0.0333	CbGbCtD
Rimonabant—CYP2C9—Capecitabine—breast cancer	0.0106	0.0314	CbGbCtD
Rimonabant—CYP3A4—Ixabepilone—breast cancer	0.0103	0.0305	CbGbCtD
Rimonabant—CYP3A4—Lapatinib—breast cancer	0.00987	0.0293	CbGbCtD
Rimonabant—CYP1A2—Tamoxifen—breast cancer	0.00943	0.028	CbGbCtD
Rimonabant—CYP2D6—Vinorelbine—breast cancer	0.00861	0.0256	CbGbCtD
Rimonabant—CYP2C9—Tamoxifen—breast cancer	0.0085	0.0252	CbGbCtD
Rimonabant—CYP2D6—Tamoxifen—breast cancer	0.00777	0.0231	CbGbCtD
Rimonabant—CYP3A4—Raloxifene—breast cancer	0.00748	0.0222	CbGbCtD
Rimonabant—CYP1A2—Fluorouracil—breast cancer	0.00695	0.0206	CbGbCtD
Rimonabant—CYP2C9—Paclitaxel—breast cancer	0.00661	0.0197	CbGbCtD
Rimonabant—CYP2C9—Fluorouracil—breast cancer	0.00626	0.0186	CbGbCtD
Rimonabant—CYP3A4—Vinorelbine—breast cancer	0.00547	0.0163	CbGbCtD
Rimonabant—CYP2D6—Vinblastine—breast cancer	0.00531	0.0158	CbGbCtD
Rimonabant—CYP3A4—Tamoxifen—breast cancer	0.00494	0.0147	CbGbCtD
Rimonabant—CYP3A4—Mitoxantrone—breast cancer	0.00482	0.0143	CbGbCtD
Rimonabant—CYP3A4—Paclitaxel—breast cancer	0.00385	0.0114	CbGbCtD
Rimonabant—CYP3A4—Irinotecan—breast cancer	0.00379	0.0113	CbGbCtD
Rimonabant—CYP3A4—Vinblastine—breast cancer	0.00337	0.01	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—breast cancer	0.00326	0.00968	CbGbCtD
Rimonabant—CYP3A4—Docetaxel—breast cancer	0.00278	0.00826	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—breast cancer	0.00207	0.00616	CbGbCtD
Rimonabant—CNR1—mammary gland—breast cancer	0.000261	0.338	CbGeAlD
Rimonabant—CNR1—adipose tissue—breast cancer	0.000117	0.152	CbGeAlD
Rimonabant—CNR1—adrenal gland—breast cancer	0.000105	0.137	CbGeAlD
Rimonabant—Mental disorder—Docetaxel—breast cancer	7.21e-05	0.000603	CcSEcCtD
Rimonabant—Mediastinal disorder—Capecitabine—breast cancer	7.18e-05	0.000601	CcSEcCtD
Rimonabant—Headache—Goserelin—breast cancer	7.18e-05	0.0006	CcSEcCtD
Rimonabant—Anxiety—Paclitaxel—breast cancer	7.17e-05	0.0006	CcSEcCtD
Rimonabant—Malnutrition—Docetaxel—breast cancer	7.17e-05	0.000599	CcSEcCtD
Rimonabant—Decreased appetite—Gemcitabine—breast cancer	7.16e-05	0.000599	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.15e-05	0.000598	CcSEcCtD
Rimonabant—Nausea—Tamoxifen—breast cancer	7.12e-05	0.000596	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Gemcitabine—breast cancer	7.12e-05	0.000595	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—breast cancer	7.11e-05	0.000594	CcSEcCtD
Rimonabant—Fatigue—Gemcitabine—breast cancer	7.11e-05	0.000594	CcSEcCtD
Rimonabant—Decreased appetite—Fluorouracil—breast cancer	7.04e-05	0.000589	CcSEcCtD
Rimonabant—Dry mouth—Paclitaxel—breast cancer	7.04e-05	0.000589	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—breast cancer	7.04e-05	0.000588	CcSEcCtD
Rimonabant—Asthenia—Thiotepa—breast cancer	7.03e-05	0.000588	CcSEcCtD
Rimonabant—Diarrhoea—Vinorelbine—breast cancer	7.02e-05	0.000587	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Fluorouracil—breast cancer	7e-05	0.000585	CcSEcCtD
Rimonabant—Mental disorder—Capecitabine—breast cancer	6.98e-05	0.000584	CcSEcCtD
Rimonabant—Nausea—Melphalan—breast cancer	6.97e-05	0.000583	CcSEcCtD
Rimonabant—Malnutrition—Capecitabine—breast cancer	6.94e-05	0.00058	CcSEcCtD
Rimonabant—Influenza—Epirubicin—breast cancer	6.94e-05	0.00058	CcSEcCtD
Rimonabant—Pruritus—Thiotepa—breast cancer	6.93e-05	0.00058	CcSEcCtD
Rimonabant—Gastrointestinal pain—Mitoxantrone—breast cancer	6.92e-05	0.000579	CcSEcCtD
Rimonabant—Gastrointestinal pain—Irinotecan—breast cancer	6.92e-05	0.000579	CcSEcCtD
Rimonabant—Muscle spasms—Docetaxel—breast cancer	6.89e-05	0.000576	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—breast cancer	6.89e-05	0.000576	CcSEcCtD
Rimonabant—Infection—Paclitaxel—breast cancer	6.86e-05	0.000573	CcSEcCtD
Rimonabant—Nausea—Goserelin—breast cancer	6.8e-05	0.000569	CcSEcCtD
Rimonabant—Dizziness—Vinorelbine—breast cancer	6.78e-05	0.000567	CcSEcCtD
Rimonabant—Nervous system disorder—Paclitaxel—breast cancer	6.77e-05	0.000566	CcSEcCtD
Rimonabant—Diarrhoea—Thiotepa—breast cancer	6.7e-05	0.000561	CcSEcCtD
Rimonabant—Skin disorder—Paclitaxel—breast cancer	6.7e-05	0.00056	CcSEcCtD
Rimonabant—Abdominal pain—Mitoxantrone—breast cancer	6.69e-05	0.000559	CcSEcCtD
Rimonabant—Abdominal pain—Irinotecan—breast cancer	6.69e-05	0.000559	CcSEcCtD
Rimonabant—Muscle spasms—Capecitabine—breast cancer	6.67e-05	0.000558	CcSEcCtD
Rimonabant—Hyperhidrosis—Paclitaxel—breast cancer	6.67e-05	0.000558	CcSEcCtD
Rimonabant—Infestation—Methotrexate—breast cancer	6.61e-05	0.000553	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—breast cancer	6.61e-05	0.000553	CcSEcCtD
Rimonabant—Depression—Methotrexate—breast cancer	6.59e-05	0.000551	CcSEcCtD
Rimonabant—Anorexia—Paclitaxel—breast cancer	6.58e-05	0.00055	CcSEcCtD
Rimonabant—Vomiting—Vinorelbine—breast cancer	6.52e-05	0.000545	CcSEcCtD
Rimonabant—Tremor—Capecitabine—breast cancer	6.5e-05	0.000544	CcSEcCtD
Rimonabant—Dizziness—Thiotepa—breast cancer	6.48e-05	0.000542	CcSEcCtD
Rimonabant—Rash—Vinorelbine—breast cancer	6.47e-05	0.000541	CcSEcCtD
Rimonabant—Dermatitis—Vinorelbine—breast cancer	6.46e-05	0.00054	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Epirubicin—breast cancer	6.45e-05	0.000539	CcSEcCtD
Rimonabant—Headache—Vinorelbine—breast cancer	6.43e-05	0.000537	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—breast cancer	6.42e-05	0.000537	CcSEcCtD
Rimonabant—CNR1—lymph node—breast cancer	6.31e-05	0.0818	CbGeAlD
Rimonabant—Insomnia—Paclitaxel—breast cancer	6.24e-05	0.000522	CcSEcCtD
Rimonabant—Vomiting—Thiotepa—breast cancer	6.23e-05	0.000521	CcSEcCtD
Rimonabant—Convulsion—Docetaxel—breast cancer	6.21e-05	0.000519	CcSEcCtD
Rimonabant—Paraesthesia—Paclitaxel—breast cancer	6.2e-05	0.000518	CcSEcCtD
Rimonabant—Infestation NOS—Epirubicin—breast cancer	6.19e-05	0.000517	CcSEcCtD
Rimonabant—Infestation—Epirubicin—breast cancer	6.19e-05	0.000517	CcSEcCtD
Rimonabant—Rash—Thiotepa—breast cancer	6.18e-05	0.000517	CcSEcCtD
Rimonabant—Dermatitis—Thiotepa—breast cancer	6.17e-05	0.000516	CcSEcCtD
Rimonabant—Headache—Thiotepa—breast cancer	6.14e-05	0.000513	CcSEcCtD
Rimonabant—Nausea—Vinorelbine—breast cancer	6.09e-05	0.00051	CcSEcCtD
Rimonabant—Asthenia—Mitoxantrone—breast cancer	6.07e-05	0.000508	CcSEcCtD
Rimonabant—Asthenia—Irinotecan—breast cancer	6.07e-05	0.000508	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.06e-05	0.000507	CcSEcCtD
Rimonabant—Decreased appetite—Paclitaxel—breast cancer	6e-05	0.000502	CcSEcCtD
Rimonabant—Dry mouth—Docetaxel—breast cancer	5.97e-05	0.000499	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—breast cancer	5.97e-05	0.000499	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Paclitaxel—breast cancer	5.96e-05	0.000498	CcSEcCtD
Rimonabant—Fatigue—Paclitaxel—breast cancer	5.95e-05	0.000497	CcSEcCtD
Rimonabant—Asthenia—Gemcitabine—breast cancer	5.91e-05	0.000494	CcSEcCtD
Rimonabant—Anxiety—Capecitabine—breast cancer	5.89e-05	0.000492	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.87e-05	0.000491	CcSEcCtD
Rimonabant—Pruritus—Gemcitabine—breast cancer	5.83e-05	0.000488	CcSEcCtD
Rimonabant—Nausea—Thiotepa—breast cancer	5.82e-05	0.000487	CcSEcCtD
Rimonabant—Infection—Docetaxel—breast cancer	5.81e-05	0.000486	CcSEcCtD
Rimonabant—Sinusitis—Epirubicin—breast cancer	5.8e-05	0.000485	CcSEcCtD
Rimonabant—Diarrhoea—Irinotecan—breast cancer	5.79e-05	0.000484	CcSEcCtD
Rimonabant—Diarrhoea—Mitoxantrone—breast cancer	5.79e-05	0.000484	CcSEcCtD
Rimonabant—Dry mouth—Capecitabine—breast cancer	5.78e-05	0.000483	CcSEcCtD
Rimonabant—Nervous system disorder—Docetaxel—breast cancer	5.74e-05	0.00048	CcSEcCtD
Rimonabant—Pruritus—Fluorouracil—breast cancer	5.73e-05	0.000479	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—breast cancer	5.72e-05	0.000479	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—breast cancer	5.72e-05	0.000479	CcSEcCtD
Rimonabant—Skin disorder—Docetaxel—breast cancer	5.68e-05	0.000475	CcSEcCtD
Rimonabant—Gastrointestinal pain—Paclitaxel—breast cancer	5.64e-05	0.000472	CcSEcCtD
Rimonabant—Diarrhoea—Gemcitabine—breast cancer	5.64e-05	0.000472	CcSEcCtD
Rimonabant—Infection—Capecitabine—breast cancer	5.63e-05	0.00047	CcSEcCtD
Rimonabant—Dizziness—Irinotecan—breast cancer	5.59e-05	0.000468	CcSEcCtD
Rimonabant—Anorexia—Docetaxel—breast cancer	5.58e-05	0.000466	CcSEcCtD
Rimonabant—Nervous system disorder—Capecitabine—breast cancer	5.55e-05	0.000464	CcSEcCtD
Rimonabant—Diarrhoea—Fluorouracil—breast cancer	5.54e-05	0.000464	CcSEcCtD
Rimonabant—Hypoaesthesia—Epirubicin—breast cancer	5.52e-05	0.000462	CcSEcCtD
Rimonabant—Skin disorder—Capecitabine—breast cancer	5.5e-05	0.00046	CcSEcCtD
Rimonabant—Hyperhidrosis—Capecitabine—breast cancer	5.47e-05	0.000458	CcSEcCtD
Rimonabant—Connective tissue disorder—Epirubicin—breast cancer	5.46e-05	0.000456	CcSEcCtD
Rimonabant—Abdominal pain—Paclitaxel—breast cancer	5.45e-05	0.000456	CcSEcCtD
Rimonabant—Anorexia—Capecitabine—breast cancer	5.4e-05	0.000451	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—breast cancer	5.38e-05	0.00045	CcSEcCtD
Rimonabant—Vomiting—Irinotecan—breast cancer	5.38e-05	0.00045	CcSEcCtD
Rimonabant—Vomiting—Mitoxantrone—breast cancer	5.38e-05	0.00045	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—breast cancer	5.37e-05	0.000449	CcSEcCtD
Rimonabant—Dizziness—Fluorouracil—breast cancer	5.36e-05	0.000448	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—breast cancer	5.35e-05	0.000447	CcSEcCtD
Rimonabant—Rash—Mitoxantrone—breast cancer	5.33e-05	0.000446	CcSEcCtD
Rimonabant—Rash—Irinotecan—breast cancer	5.33e-05	0.000446	CcSEcCtD
Rimonabant—Dermatitis—Mitoxantrone—breast cancer	5.33e-05	0.000446	CcSEcCtD
Rimonabant—Dermatitis—Irinotecan—breast cancer	5.33e-05	0.000446	CcSEcCtD
Rimonabant—Headache—Mitoxantrone—breast cancer	5.3e-05	0.000443	CcSEcCtD
Rimonabant—Headache—Irinotecan—breast cancer	5.3e-05	0.000443	CcSEcCtD
Rimonabant—Insomnia—Docetaxel—breast cancer	5.29e-05	0.000442	CcSEcCtD
Rimonabant—Paraesthesia—Docetaxel—breast cancer	5.25e-05	0.000439	CcSEcCtD
Rimonabant—Vomiting—Gemcitabine—breast cancer	5.24e-05	0.000438	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—breast cancer	5.2e-05	0.000435	CcSEcCtD
Rimonabant—Rash—Gemcitabine—breast cancer	5.2e-05	0.000435	CcSEcCtD
Rimonabant—Dermatitis—Gemcitabine—breast cancer	5.19e-05	0.000434	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—breast cancer	5.17e-05	0.000432	CcSEcCtD
Rimonabant—Headache—Gemcitabine—breast cancer	5.16e-05	0.000432	CcSEcCtD
Rimonabant—Vomiting—Fluorouracil—breast cancer	5.15e-05	0.000431	CcSEcCtD
Rimonabant—Insomnia—Capecitabine—breast cancer	5.12e-05	0.000428	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—breast cancer	5.11e-05	0.000427	CcSEcCtD
Rimonabant—Rash—Fluorouracil—breast cancer	5.11e-05	0.000427	CcSEcCtD
Rimonabant—Dermatitis—Fluorouracil—breast cancer	5.1e-05	0.000427	CcSEcCtD
Rimonabant—Paraesthesia—Capecitabine—breast cancer	5.08e-05	0.000425	CcSEcCtD
Rimonabant—Decreased appetite—Docetaxel—breast cancer	5.08e-05	0.000425	CcSEcCtD
Rimonabant—Headache—Fluorouracil—breast cancer	5.08e-05	0.000425	CcSEcCtD
Rimonabant—CYP2C9—mammary gland—breast cancer	5.05e-05	0.0655	CbGeAlD
Rimonabant—Gastrointestinal disorder—Docetaxel—breast cancer	5.05e-05	0.000422	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—breast cancer	5.05e-05	0.000422	CcSEcCtD
Rimonabant—Fatigue—Docetaxel—breast cancer	5.04e-05	0.000422	CcSEcCtD
Rimonabant—Angiopathy—Epirubicin—breast cancer	5.04e-05	0.000421	CcSEcCtD
Rimonabant—Nausea—Mitoxantrone—breast cancer	5.03e-05	0.00042	CcSEcCtD
Rimonabant—Nausea—Irinotecan—breast cancer	5.03e-05	0.00042	CcSEcCtD
Rimonabant—Mediastinal disorder—Epirubicin—breast cancer	5e-05	0.000418	CcSEcCtD
Rimonabant—Asthenia—Paclitaxel—breast cancer	4.95e-05	0.000414	CcSEcCtD
Rimonabant—Decreased appetite—Capecitabine—breast cancer	4.92e-05	0.000412	CcSEcCtD
Rimonabant—Nausea—Gemcitabine—breast cancer	4.9e-05	0.000409	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Capecitabine—breast cancer	4.89e-05	0.000409	CcSEcCtD
Rimonabant—Fatigue—Capecitabine—breast cancer	4.88e-05	0.000408	CcSEcCtD
Rimonabant—Pruritus—Paclitaxel—breast cancer	4.88e-05	0.000408	CcSEcCtD
Rimonabant—Mental disorder—Epirubicin—breast cancer	4.86e-05	0.000407	CcSEcCtD
Rimonabant—Malnutrition—Epirubicin—breast cancer	4.83e-05	0.000404	CcSEcCtD
Rimonabant—Nausea—Fluorouracil—breast cancer	4.81e-05	0.000403	CcSEcCtD
Rimonabant—Gastrointestinal pain—Docetaxel—breast cancer	4.78e-05	0.0004	CcSEcCtD
Rimonabant—Tension—Epirubicin—breast cancer	4.74e-05	0.000397	CcSEcCtD
Rimonabant—Diarrhoea—Paclitaxel—breast cancer	4.72e-05	0.000395	CcSEcCtD
Rimonabant—Nervousness—Epirubicin—breast cancer	4.69e-05	0.000393	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—breast cancer	4.66e-05	0.00039	CcSEcCtD
Rimonabant—Muscle spasms—Epirubicin—breast cancer	4.65e-05	0.000389	CcSEcCtD
Rimonabant—Gastrointestinal pain—Capecitabine—breast cancer	4.63e-05	0.000387	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—breast cancer	4.63e-05	0.000387	CcSEcCtD
Rimonabant—Abdominal pain—Docetaxel—breast cancer	4.62e-05	0.000387	CcSEcCtD
Rimonabant—Dizziness—Paclitaxel—breast cancer	4.56e-05	0.000382	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—breast cancer	4.5e-05	0.000376	CcSEcCtD
Rimonabant—Abdominal pain—Capecitabine—breast cancer	4.48e-05	0.000374	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—breast cancer	4.48e-05	0.000374	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—breast cancer	4.47e-05	0.000374	CcSEcCtD
Rimonabant—CYP1A2—nipple—breast cancer	4.4e-05	0.0571	CbGeAlD
Rimonabant—Tension—Doxorubicin—breast cancer	4.39e-05	0.000367	CcSEcCtD
Rimonabant—Vomiting—Paclitaxel—breast cancer	4.39e-05	0.000367	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.37e-05	0.000365	CcSEcCtD
Rimonabant—Rash—Paclitaxel—breast cancer	4.35e-05	0.000364	CcSEcCtD
Rimonabant—Dermatitis—Paclitaxel—breast cancer	4.35e-05	0.000363	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—breast cancer	4.34e-05	0.000363	CcSEcCtD
Rimonabant—Headache—Paclitaxel—breast cancer	4.32e-05	0.000361	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—breast cancer	4.3e-05	0.00036	CcSEcCtD
Rimonabant—Asthenia—Docetaxel—breast cancer	4.2e-05	0.000351	CcSEcCtD
Rimonabant—Convulsion—Epirubicin—breast cancer	4.19e-05	0.00035	CcSEcCtD
Rimonabant—Infection—Methotrexate—breast cancer	4.19e-05	0.00035	CcSEcCtD
Rimonabant—Pruritus—Docetaxel—breast cancer	4.14e-05	0.000346	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—breast cancer	4.13e-05	0.000346	CcSEcCtD
Rimonabant—Anxiety—Epirubicin—breast cancer	4.1e-05	0.000343	CcSEcCtD
Rimonabant—Nausea—Paclitaxel—breast cancer	4.1e-05	0.000343	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—breast cancer	4.09e-05	0.000342	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.09e-05	0.000342	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—breast cancer	4.08e-05	0.000341	CcSEcCtD
Rimonabant—Asthenia—Capecitabine—breast cancer	4.06e-05	0.00034	CcSEcCtD
Rimonabant—Dry mouth—Epirubicin—breast cancer	4.02e-05	0.000337	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—breast cancer	4.02e-05	0.000336	CcSEcCtD
Rimonabant—Pruritus—Capecitabine—breast cancer	4.01e-05	0.000335	CcSEcCtD
Rimonabant—Diarrhoea—Docetaxel—breast cancer	4e-05	0.000335	CcSEcCtD
Rimonabant—Infection—Epirubicin—breast cancer	3.92e-05	0.000328	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—breast cancer	3.88e-05	0.000324	CcSEcCtD
Rimonabant—Diarrhoea—Capecitabine—breast cancer	3.87e-05	0.000324	CcSEcCtD
Rimonabant—Nervous system disorder—Epirubicin—breast cancer	3.87e-05	0.000324	CcSEcCtD
Rimonabant—Dizziness—Docetaxel—breast cancer	3.87e-05	0.000323	CcSEcCtD
Rimonabant—Skin disorder—Epirubicin—breast cancer	3.83e-05	0.00032	CcSEcCtD
Rimonabant—Hyperhidrosis—Epirubicin—breast cancer	3.81e-05	0.000319	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—breast cancer	3.81e-05	0.000319	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—breast cancer	3.79e-05	0.000317	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—breast cancer	3.79e-05	0.000317	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.78e-05	0.000316	CcSEcCtD
Rimonabant—Anorexia—Epirubicin—breast cancer	3.76e-05	0.000314	CcSEcCtD
Rimonabant—Dizziness—Capecitabine—breast cancer	3.74e-05	0.000313	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—breast cancer	3.72e-05	0.000311	CcSEcCtD
Rimonabant—Vomiting—Docetaxel—breast cancer	3.72e-05	0.000311	CcSEcCtD
Rimonabant—Rash—Docetaxel—breast cancer	3.69e-05	0.000308	CcSEcCtD
Rimonabant—Dermatitis—Docetaxel—breast cancer	3.68e-05	0.000308	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—breast cancer	3.66e-05	0.000306	CcSEcCtD
Rimonabant—Headache—Docetaxel—breast cancer	3.66e-05	0.000306	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—breast cancer	3.64e-05	0.000304	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—breast cancer	3.63e-05	0.000304	CcSEcCtD
Rimonabant—Infection—Doxorubicin—breast cancer	3.63e-05	0.000303	CcSEcCtD
Rimonabant—Vomiting—Capecitabine—breast cancer	3.6e-05	0.000301	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—breast cancer	3.58e-05	0.000299	CcSEcCtD
Rimonabant—Rash—Capecitabine—breast cancer	3.57e-05	0.000299	CcSEcCtD
Rimonabant—Insomnia—Epirubicin—breast cancer	3.57e-05	0.000298	CcSEcCtD
Rimonabant—Dermatitis—Capecitabine—breast cancer	3.57e-05	0.000298	CcSEcCtD
Rimonabant—Headache—Capecitabine—breast cancer	3.55e-05	0.000297	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—breast cancer	3.55e-05	0.000296	CcSEcCtD
Rimonabant—Paraesthesia—Epirubicin—breast cancer	3.54e-05	0.000296	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—breast cancer	3.53e-05	0.000295	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—breast cancer	3.48e-05	0.000291	CcSEcCtD
Rimonabant—Nausea—Docetaxel—breast cancer	3.47e-05	0.000291	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—breast cancer	3.45e-05	0.000288	CcSEcCtD
Rimonabant—Decreased appetite—Epirubicin—breast cancer	3.43e-05	0.000287	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Epirubicin—breast cancer	3.41e-05	0.000285	CcSEcCtD
Rimonabant—Fatigue—Epirubicin—breast cancer	3.4e-05	0.000284	CcSEcCtD
Rimonabant—Nausea—Capecitabine—breast cancer	3.36e-05	0.000281	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—breast cancer	3.33e-05	0.000279	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—breast cancer	3.3e-05	0.000276	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—breast cancer	3.28e-05	0.000274	CcSEcCtD
Rimonabant—Gastrointestinal pain—Epirubicin—breast cancer	3.23e-05	0.00027	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—breast cancer	3.17e-05	0.000265	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—breast cancer	3.15e-05	0.000264	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—breast cancer	3.15e-05	0.000263	CcSEcCtD
Rimonabant—Abdominal pain—Epirubicin—breast cancer	3.12e-05	0.000261	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—breast cancer	3.02e-05	0.000253	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—breast cancer	2.98e-05	0.00025	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—breast cancer	2.98e-05	0.000249	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—breast cancer	2.89e-05	0.000241	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—breast cancer	2.88e-05	0.000241	CcSEcCtD
Rimonabant—Asthenia—Epirubicin—breast cancer	2.83e-05	0.000237	CcSEcCtD
Rimonabant—Pruritus—Epirubicin—breast cancer	2.79e-05	0.000233	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—breast cancer	2.79e-05	0.000233	CcSEcCtD
Rimonabant—Diarrhoea—Epirubicin—breast cancer	2.7e-05	0.000226	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—breast cancer	2.68e-05	0.000224	CcSEcCtD
Rimonabant—Rash—Methotrexate—breast cancer	2.66e-05	0.000222	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—breast cancer	2.66e-05	0.000222	CcSEcCtD
Rimonabant—Headache—Methotrexate—breast cancer	2.64e-05	0.000221	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—breast cancer	2.62e-05	0.000219	CcSEcCtD
Rimonabant—Dizziness—Epirubicin—breast cancer	2.61e-05	0.000218	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—breast cancer	2.58e-05	0.000216	CcSEcCtD
Rimonabant—Vomiting—Epirubicin—breast cancer	2.51e-05	0.00021	CcSEcCtD
Rimonabant—Nausea—Methotrexate—breast cancer	2.5e-05	0.000209	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—breast cancer	2.5e-05	0.000209	CcSEcCtD
Rimonabant—Rash—Epirubicin—breast cancer	2.49e-05	0.000208	CcSEcCtD
Rimonabant—Dermatitis—Epirubicin—breast cancer	2.49e-05	0.000208	CcSEcCtD
Rimonabant—Headache—Epirubicin—breast cancer	2.47e-05	0.000207	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—breast cancer	2.41e-05	0.000202	CcSEcCtD
Rimonabant—Nausea—Epirubicin—breast cancer	2.34e-05	0.000196	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—breast cancer	2.32e-05	0.000194	CcSEcCtD
Rimonabant—Rash—Doxorubicin—breast cancer	2.3e-05	0.000192	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—breast cancer	2.3e-05	0.000192	CcSEcCtD
Rimonabant—Headache—Doxorubicin—breast cancer	2.29e-05	0.000191	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—breast cancer	2.17e-05	0.000181	CcSEcCtD
Rimonabant—CYP2C9—female reproductive system—breast cancer	2.09e-05	0.0271	CbGeAlD
Rimonabant—CYP1A2—endocrine gland—breast cancer	1.86e-05	0.0242	CbGeAlD
Rimonabant—CYP2C9—endocrine gland—breast cancer	1.77e-05	0.0229	CbGeAlD
Rimonabant—CYP3A4—female reproductive system—breast cancer	1.59e-05	0.0207	CbGeAlD
Rimonabant—CYP2D6—female reproductive system—breast cancer	1.57e-05	0.0203	CbGeAlD
Rimonabant—CYP2D6—female gonad—breast cancer	1.43e-05	0.0185	CbGeAlD
Rimonabant—CYP3A4—endocrine gland—breast cancer	1.35e-05	0.0175	CbGeAlD
Rimonabant—CYP2D6—endocrine gland—breast cancer	1.33e-05	0.0172	CbGeAlD
Rimonabant—CNR1—Signaling Pathways—PIK3CA—breast cancer	5.03e-06	7.05e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SULT1A1—breast cancer	5.02e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX4—breast cancer	5.02e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—DPYD—breast cancer	5.02e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MED12—breast cancer	5.02e-06	7.03e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—DPYD—breast cancer	4.98e-06	6.97e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MED12—breast cancer	4.98e-06	6.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALDOA—breast cancer	4.94e-06	6.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDH7A1—breast cancer	4.94e-06	6.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDH1A1—breast cancer	4.94e-06	6.92e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTA1—breast cancer	4.9e-06	6.87e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH1—breast cancer	4.9e-06	6.87e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALDOA—breast cancer	4.9e-06	6.86e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TP53—breast cancer	4.87e-06	6.82e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NAT2—breast cancer	4.85e-06	6.79e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA3—breast cancer	4.8e-06	6.72e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A2—breast cancer	4.76e-06	6.67e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA3—breast cancer	4.76e-06	6.66e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FHL2—breast cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NME1—breast cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—UMPS—breast cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADSL—breast cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PHGDH—breast cancer	4.73e-06	6.63e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A2—breast cancer	4.72e-06	6.61e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	4.67e-06	6.55e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCG2—breast cancer	4.67e-06	6.54e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CPT1A—breast cancer	4.67e-06	6.54e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTR—breast cancer	4.67e-06	6.54e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—HRAS—breast cancer	4.65e-06	6.52e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—LDHB—breast cancer	4.64e-06	6.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BRIP1—breast cancer	4.64e-06	6.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HPSE—breast cancer	4.64e-06	6.5e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTR—breast cancer	4.63e-06	6.48e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CPT1A—breast cancer	4.63e-06	6.48e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCG2—breast cancer	4.63e-06	6.48e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HPGDS—breast cancer	4.58e-06	6.41e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HBA1—breast cancer	4.55e-06	6.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HPGDS—breast cancer	4.54e-06	6.36e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HBA1—breast cancer	4.51e-06	6.32e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—breast cancer	4.45e-06	6.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTT1—breast cancer	4.44e-06	6.22e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACHE—breast cancer	4.44e-06	6.22e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCC1—breast cancer	4.4e-06	6.17e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA3—breast cancer	4.4e-06	6.17e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMMR—breast cancer	4.4e-06	6.17e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACHE—breast cancer	4.4e-06	6.16e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTT1—breast cancer	4.4e-06	6.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	4.38e-06	6.14e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PPARGC1B—breast cancer	4.26e-06	5.97e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MED12—breast cancer	4.25e-06	5.96e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—DPYD—breast cancer	4.25e-06	5.96e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP17A1—breast cancer	4.2e-06	5.89e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALDOA—breast cancer	4.19e-06	5.86e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP17A1—breast cancer	4.16e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO1—breast cancer	4.16e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS1—breast cancer	4.16e-06	5.83e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS1—breast cancer	4.12e-06	5.78e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO1—breast cancer	4.12e-06	5.78e-05	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—AKT1—breast cancer	4.11e-06	5.76e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	4.11e-06	5.75e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA3—breast cancer	4.06e-06	5.69e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	4.06e-06	5.68e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP2D6—breast cancer	4.04e-06	5.66e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A2—breast cancer	4.03e-06	5.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA4—breast cancer	4.03e-06	5.64e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA9—breast cancer	4.03e-06	5.64e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA2—breast cancer	4e-06	5.61e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	3.99e-06	5.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA2—breast cancer	3.97e-06	5.56e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTR—breast cancer	3.95e-06	5.54e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CPT1A—breast cancer	3.95e-06	5.54e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCG2—breast cancer	3.95e-06	5.54e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA2—breast cancer	3.92e-06	5.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX2—breast cancer	3.92e-06	5.5e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FASN—breast cancer	3.88e-06	5.44e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HPGDS—breast cancer	3.88e-06	5.43e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SULT1A1—breast cancer	3.87e-06	5.43e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX4—breast cancer	3.87e-06	5.43e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—BCHE—breast cancer	3.87e-06	5.42e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HBA1—breast cancer	3.85e-06	5.4e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FASN—breast cancer	3.85e-06	5.39e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—BCHE—breast cancer	3.83e-06	5.37e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC5A5—breast cancer	3.82e-06	5.35e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC5A5—breast cancer	3.79e-06	5.3e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH1—breast cancer	3.78e-06	5.3e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTA1—breast cancer	3.78e-06	5.3e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACHE—breast cancer	3.76e-06	5.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTT1—breast cancer	3.76e-06	5.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NAT2—breast cancer	3.74e-06	5.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NQO1—breast cancer	3.69e-06	5.17e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—SLC2A1—breast cancer	3.69e-06	5.17e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—SLC2A1—breast cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NQO1—breast cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP3A4—breast cancer	3.6e-06	5.04e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.58e-06	5.02e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP3A4—breast cancer	3.57e-06	5e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP17A1—breast cancer	3.56e-06	4.99e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.55e-06	4.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1B1—breast cancer	3.54e-06	4.95e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO1—breast cancer	3.52e-06	4.94e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS1—breast cancer	3.52e-06	4.94e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	3.51e-06	4.92e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1B1—breast cancer	3.51e-06	4.91e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HSP90AA1—breast cancer	3.47e-06	4.86e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	3.47e-06	4.85e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP2D6—breast cancer	3.46e-06	4.84e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HSP90AA1—breast cancer	3.44e-06	4.82e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA2—breast cancer	3.39e-06	4.75e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOA1—breast cancer	3.37e-06	4.73e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOA1—breast cancer	3.34e-06	4.69e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP19A1—breast cancer	3.32e-06	4.66e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—STK11—breast cancer	3.32e-06	4.66e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—STK11—breast cancer	3.3e-06	4.62e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP19A1—breast cancer	3.3e-06	4.62e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FASN—breast cancer	3.29e-06	4.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MED12—breast cancer	3.28e-06	4.6e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—DPYD—breast cancer	3.28e-06	4.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—BCHE—breast cancer	3.28e-06	4.59e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC5A5—breast cancer	3.24e-06	4.53e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALDOA—breast cancer	3.23e-06	4.53e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA3—breast cancer	3.14e-06	4.39e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NQO1—breast cancer	3.12e-06	4.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—SLC2A1—breast cancer	3.12e-06	4.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A2—breast cancer	3.11e-06	4.36e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.09e-06	4.33e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—COMT—breast cancer	3.09e-06	4.33e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTP1—breast cancer	3.08e-06	4.31e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—COMT—breast cancer	3.06e-06	4.29e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.06e-06	4.29e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTR—breast cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CPT1A—breast cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCG2—breast cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTP1—breast cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP3A4—breast cancer	3.05e-06	4.27e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—HMOX1—breast cancer	3.03e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.03e-06	4.25e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ITPR1—breast cancer	3.03e-06	4.24e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—HMOX1—breast cancer	3.01e-06	4.21e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ITPR1—breast cancer	3e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1B1—breast cancer	3e-06	4.2e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HPGDS—breast cancer	2.99e-06	4.19e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HBA1—breast cancer	2.97e-06	4.16e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.94e-06	4.12e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ABCB1—breast cancer	2.91e-06	4.08e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTT1—breast cancer	2.9e-06	4.07e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACHE—breast cancer	2.9e-06	4.07e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ABCB1—breast cancer	2.89e-06	4.04e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TYMS—breast cancer	2.86e-06	4.01e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOA1—breast cancer	2.86e-06	4e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TYMS—breast cancer	2.84e-06	3.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NCOR1—breast cancer	2.83e-06	3.96e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.83e-06	3.96e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GSTM1—breast cancer	2.83e-06	3.96e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP19A1—breast cancer	2.82e-06	3.95e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—STK11—breast cancer	2.82e-06	3.95e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.8e-06	3.93e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NCOR1—breast cancer	2.8e-06	3.93e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GSTM1—breast cancer	2.8e-06	3.93e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP17A1—breast cancer	2.75e-06	3.85e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO1—breast cancer	2.72e-06	3.81e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS1—breast cancer	2.72e-06	3.81e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—breast cancer	2.71e-06	3.79e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—breast cancer	2.68e-06	3.76e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP1A1—breast cancer	2.68e-06	3.75e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP2D6—breast cancer	2.67e-06	3.74e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ERCC2—breast cancer	2.66e-06	3.72e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP1A1—breast cancer	2.66e-06	3.72e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.64e-06	3.7e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ERCC2—breast cancer	2.64e-06	3.69e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—COMT—breast cancer	2.62e-06	3.67e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA2—breast cancer	2.62e-06	3.67e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTP1—breast cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—HMOX1—breast cancer	2.57e-06	3.6e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ITPR1—breast cancer	2.56e-06	3.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FASN—breast cancer	2.54e-06	3.56e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—BCHE—breast cancer	2.53e-06	3.54e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—breast cancer	2.5e-06	3.5e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC5A5—breast cancer	2.5e-06	3.5e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—breast cancer	2.48e-06	3.47e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ABCB1—breast cancer	2.47e-06	3.46e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TYMS—breast cancer	2.42e-06	3.39e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NQO1—breast cancer	2.41e-06	3.38e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—SLC2A1—breast cancer	2.41e-06	3.38e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GSTM1—breast cancer	2.39e-06	3.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PLA2G4A—breast cancer	2.39e-06	3.36e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NCOR1—breast cancer	2.39e-06	3.36e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1B1—breast cancer	2.31e-06	3.24e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CAV1—breast cancer	2.3e-06	3.23e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—breast cancer	2.29e-06	3.21e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CAV1—breast cancer	2.28e-06	3.2e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP1A1—breast cancer	2.27e-06	3.18e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.27e-06	3.18e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ERCC2—breast cancer	2.25e-06	3.15e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOA1—breast cancer	2.21e-06	3.09e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.18e-06	3.06e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—STK11—breast cancer	2.17e-06	3.05e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP19A1—breast cancer	2.17e-06	3.05e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—breast cancer	2.12e-06	2.97e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CG—breast cancer	2.1e-06	2.94e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CG—breast cancer	2.08e-06	2.92e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—COMT—breast cancer	2.02e-06	2.83e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTP1—breast cancer	2.01e-06	2.82e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—HMOX1—breast cancer	1.98e-06	2.78e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ITPR1—breast cancer	1.98e-06	2.77e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CAV1—breast cancer	1.95e-06	2.74e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ABCB1—breast cancer	1.9e-06	2.67e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TYMS—breast cancer	1.87e-06	2.62e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.87e-06	2.61e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NCOR1—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GSTM1—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CD—breast cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CD—breast cancer	1.83e-06	2.56e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ALB—breast cancer	1.82e-06	2.55e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ALB—breast cancer	1.81e-06	2.53e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CG—breast cancer	1.78e-06	2.49e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—breast cancer	1.77e-06	2.48e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP1A1—breast cancer	1.75e-06	2.45e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—NOS3—breast cancer	1.74e-06	2.44e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ERCC2—breast cancer	1.74e-06	2.43e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—NOS3—breast cancer	1.73e-06	2.42e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—breast cancer	1.63e-06	2.29e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CB—breast cancer	1.61e-06	2.25e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CB—breast cancer	1.59e-06	2.23e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTGS2—breast cancer	1.59e-06	2.23e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTGS2—breast cancer	1.58e-06	2.21e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CD—breast cancer	1.56e-06	2.19e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ALB—breast cancer	1.54e-06	2.16e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CAV1—breast cancer	1.51e-06	2.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—NOS3—breast cancer	1.48e-06	2.07e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PTEN—breast cancer	1.39e-06	1.95e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PTEN—breast cancer	1.38e-06	1.93e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CG—breast cancer	1.37e-06	1.92e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CB—breast cancer	1.36e-06	1.91e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTGS2—breast cancer	1.35e-06	1.89e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CD—breast cancer	1.21e-06	1.69e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ALB—breast cancer	1.19e-06	1.67e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PTEN—breast cancer	1.18e-06	1.65e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—NOS3—breast cancer	1.14e-06	1.6e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CB—breast cancer	1.05e-06	1.47e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTGS2—breast cancer	1.04e-06	1.46e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PIK3CA—breast cancer	9.81e-07	1.37e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PIK3CA—breast cancer	9.72e-07	1.36e-05	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PTEN—breast cancer	9.09e-07	1.27e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PIK3CA—breast cancer	8.31e-07	1.16e-05	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—AKT1—breast cancer	8.01e-07	1.12e-05	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—AKT1—breast cancer	7.94e-07	1.11e-05	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—AKT1—breast cancer	6.79e-07	9.51e-06	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PIK3CA—breast cancer	6.41e-07	8.98e-06	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—AKT1—breast cancer	5.24e-07	7.34e-06	CbGpPWpGaD
